Review Article
Nanomaterials for the Local and Targeted Delivery of Osteoarthritis Drugs
Table 2
Targeted micelle formulations.
| Ligand type | Ligand | Target | Copolymer | Reference |
| Antibody | mAb 2C5 | Nucleosome-restricted specificity for different cancer cells | PEG-b-PE | [54] | mAb C225 | EGF receptor | PEG-b-PG | [55] | mAb HD39-SA | CD22 | Biotinylated PDMAEMA-b-DMAEMA-BMA-PAA | [56] |
| Peptide | ligand (cRGDfK) | integrin | PEG-b-PCL | [57] | VPAC2 | Vasoactive intestinal peptide receptor | DSPE-PEG3400-NHS | [58] | Angiopep-2 | Lipoprotein receptor-related protein (LRP) present on the BBB | PE-PEG | [59] | WYRGRL | Collagen II α1 | Pluronic F-127 | [31] |
| Others |
Folate |
Folate receptor | PLGA-b-PEG | [60] | mPEG-b-PCL | [61] | PEG3350-DSPE: mPEG2300-DSPE(1 : 100) | [62] | Galactosamine | Asialoglycoprotein receptor (ASGP-R) | PCL67-PEEP36-CDI | [63] |
|
|